000952SZSE
🚨 Material Event

Announcement on Disclosure of the Revised Draft Plan for Issuing A Shares to Specific Objects in 2026

Guangji Pharmaceutical Co., Ltd.··1 page

✨ AI Summary

Hubei Guangji Pharmaceutical Co., Ltd. announced that its board of directors approved the revised draft plan for issuing A shares to specific objects in 2026. The plan and related documents are available on CNINFO. The issuance is subject to regulatory approval, shareholder approval, and stock exchange review, with an uncertain outcome.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Stock Code: 000952

Stock Abbreviation: Guangji Pharmaceutical

Announcement No.: 2026-055

Hubei Guangji Pharmaceutical Co., Ltd.

Announcement on Disclosure of the Revised Draft Plan for Issuing A Shares to Specific Objects in 2026

The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or major omissions.

Hubei Guangji Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") convened the 19th (Extraordinary) Meeting of the 11th Board of Directors on July

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.